全文获取类型
收费全文 | 965篇 |
免费 | 58篇 |
出版年
2023年 | 3篇 |
2022年 | 7篇 |
2021年 | 26篇 |
2020年 | 13篇 |
2019年 | 10篇 |
2018年 | 22篇 |
2017年 | 21篇 |
2016年 | 33篇 |
2015年 | 54篇 |
2014年 | 53篇 |
2013年 | 52篇 |
2012年 | 84篇 |
2011年 | 81篇 |
2010年 | 52篇 |
2009年 | 45篇 |
2008年 | 56篇 |
2007年 | 72篇 |
2006年 | 62篇 |
2005年 | 43篇 |
2004年 | 54篇 |
2003年 | 51篇 |
2002年 | 31篇 |
2001年 | 8篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1998年 | 10篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 8篇 |
1994年 | 5篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 5篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 9篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1977年 | 2篇 |
1974年 | 2篇 |
排序方式: 共有1023条查询结果,搜索用时 15 毫秒
971.
Árpád Kovács Judit Kalász Enikő T. Pásztor Attila Tóth Zoltán Papp Naranjan S. Dhalla Judit Barta 《Molecular and cellular biochemistry》2017,424(1-2):57-67
C1ql-like (C1QL)-1 and -4 proteins are encoded by homologous genes that are highly expressed in brain and adipose tissues. However, functional properties of C1QL proteins outside of the brain and adipocytes remain unknown. Here, we report that the globular domain of C1ql1/Ctrp14 and C1ql4/Ctrp11 proteins directly stimulate the angiogenesis of endothelial cells. In this study, soluble C1ql1/CTRP14 and C1ql4/Ctrp11 proteins, produced in prokaryote expression system, are co-cultured with human umbilical vein endothelium cells (HUVECs), which phenotype is identified with von Willebrand factor antibody. C1ql1/Ctrp14 and C1ql4/Ctrp11 promote the migration and capillary tube formation of HUVECs in a dose-dependent manner. During this process, phosphorylation of c-Raf, MEK1/2, ERK1/2, and p90RSK are activated by C1ql1/Ctrp14 and C1ql4/Ctrp11. MEK1/2 inhibitor, U0126, blocks C1ql1/Ctrp14-, and C1ql4/Ctrp11-induced capillary tube formation and cell migration. Moreover, the immunoreactivity of the receptor of C1QL1-C1QL4, brain-specific angiogenesis inhibitor 3 (BAI3), is detected in HUVECs, suggesting that BAI3 may mediate C1QL1/CTRP14- and C1QL4/CTRP11-induced angiogenesis. Meanwhile, C1ql1/Ctrp14 and C1ql4/Ctrp11 exposure also causes a stimulatory response of angiogenesis in chick yolk sac membrane. These data demonstrate that C1ql1/Ctrp14 and C1ql4/Ctrp11 stimulate the new blood vessel growth by activation of ERK1/2 signal pathway. The proangiogenic activity of C1ql1/Ctrp14 and C1ql4/Ctrp11 provides novel insights into the new opportunities for therapeutic intervention by targeting C1QLs in tumorigenesis, tissue regeneration, and recovery of ischemic heart disease. 相似文献
972.
Gábor Borics Gábor Várbíró János Falucskai Zsolt Végvári Enikő T-Krasznai Judit Görgényi Viktória B-Béres Verona Lerf 《Freshwater Biology》2023,68(1):115-126
- Body metrics are considered as master traits that regulate physiological, behavioural and life history features of planktic cyanobacteria and microalgae. Although the distribution of their morphological traits reflects the various trade-offs and strategies needed for survival in pelagic habitats, previous methods for quantifying phytoplankton body shape do not adequately represent the intricate details of surface variation that are so important for their nutrient- and light-harvesting capabilities. Therefore, here we provide a new framework to quantify and illustrate the morphological diversity of cyanobacteria and microalgae.
- Essential components of formulae used for surface area (A = Cs × d2) and volume (V = Cv × d3) calculations are provided by the shape-specific surface area and volume constants (Cs, Cv). Cs, the surface shape factor, characterises the coarseness of the object surface, and Cv, the volumetric shape factor, characterises the shape deviation from a sphere. Using these morphologically and biologically relevant variables, we defined a two-dimensional morphological space, in which all three-dimensional objects have well-defined positions.
- By analysing morphologies of taxa representing various forms in major cyanobacterial and microalgal groups, we demonstrated that these groups show considerable differences in the area occupied within the morphospace and these differences are not affected by evolutionary relatedness. We showed that the ratio of surface and volume constants correlated with organism size, suggesting that the development of basic morphologies is constrained by their linear dimensions.
- Using surface and volumetric shape factors, we created a two-dimensional Euclidean morphospace in which all three-dimensional objects have a specific position. Positioning uni- and multicellular cyanobacteria and microalgae of various shapes into this morphospace allows their geometrical and ecological limitations to be understood. Because of the close linkage between phytoplankton morphology and ecology, the proposed morphospace may serve as a proxy for an ecospace. Thus, in future the proposed morphospace can be used to visualise current ecological processes such as eutrophication or seasonal succession of phytoplankton.
973.
974.
975.
976.
977.
Mrten Alkmark Judit K. J. Keulen Joep C. Kortekaas Christina Bergh Jeroen van Dillen Ruben G. Duijnhoven Henrik Hagberg Ben Willem Mol Mattias Molin Joris A. M. van der Post Sissel Saltvedt Anna-Karin Wikstrm Ulla-Britt Wennerholm Esteriek de Miranda 《PLoS medicine》2020,17(12)
BackgroundThe risk of perinatal death and severe neonatal morbidity increases gradually after 41 weeks of pregnancy. Several randomised controlled trials (RCTs) have assessed if induction of labour (IOL) in uncomplicated pregnancies at 41 weeks will improve perinatal outcomes. We performed an individual participant data meta-analysis (IPD-MA) on this subject.Methods and findingsWe searched PubMed, Excerpta Medica dataBASE (Embase), The Cochrane Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and PsycINFO on February 21, 2020 for RCTs comparing IOL at 41 weeks with expectant management until 42 weeks in women with uncomplicated pregnancies. Individual participant data (IPD) were sought from eligible RCTs. Primary outcome was a composite of severe adverse perinatal outcomes: mortality and severe neonatal morbidity. Additional outcomes included neonatal admission, mode of delivery, perineal lacerations, and postpartum haemorrhage. Prespecified subgroup analyses were conducted for parity (nulliparous/multiparous), maternal age (<35/≥35 years), and body mass index (BMI) (<30/≥30). Aggregate data meta-analysis (MA) was performed to include data from RCTs for which IPD was not available.From 89 full-text articles, we identified three eligible RCTs (n = 5,161), and two contributed with IPD (n = 4,561). Baseline characteristics were similar between the groups regarding age, parity, BMI, and higher level of education. IOL resulted overall in a decrease of severe adverse perinatal outcome (0.4% [10/2,281] versus 1.0% [23/2,280]; relative risk [RR] 0.43 [95% confidence interval [CI] 0.21 to 0.91], p-value 0.027, risk difference [RD] −57/10,000 [95% CI −106/10,000 to −8/10,000], I2 0%). The number needed to treat (NNT) was 175 (95% CI 94 to 1,267).Perinatal deaths occurred in one (<0.1%) versus eight (0.4%) pregnancies (Peto odds ratio [OR] 0.21 [95% CI 0.06 to 0.78], p-value 0.019, RD −31/10,000, [95% CI −56/10,000 to −5/10,000], I2 0%, NNT 326, [95% CI 177 to 2,014]) and admission to a neonatal care unit ≥4 days occurred in 1.1% (24/2,280) versus 1.9% (46/2,273), (RR 0.52 [95% CI 0.32 to 0.85], p-value 0.009, RD −97/10,000 [95% CI −169/10,000 to −26/10,000], I2 0%, NNT 103 [95% CI 59 to 385]). There was no difference in the rate of cesarean delivery (10.5% versus 10.7%; RR 0.98, [95% CI 0.83 to 1.16], p-value 0.81) nor in other important perinatal, delivery, and maternal outcomes. MA on aggregate data showed similar results.Prespecified subgroup analyses for the primary outcome showed a significant difference in the treatment effect (p = 0.01 for interaction) for parity, but not for maternal age or BMI. The risk of severe adverse perinatal outcome was decreased for nulliparous women in the IOL group (0.3% [4/1,219] versus 1.6% [20/1,264]; RR 0.20 [95% CI 0.07 to 0.60], p-value 0.004, RD −127/10,000, [95% CI −204/10,000 to −50/10,000], I2 0%, NNT 79 [95% CI 49 to 201]) but not for multiparous women (0.6% [6/1,219] versus 0.3% [3/1,264]; RR 1.59 [95% CI 0.15 to 17.30], p-value 0.35, RD 27/10,000, [95% CI −29/10,000 to 84/10,000], I2 55%).A limitation of this IPD-MA was the risk of overestimation of the effect on perinatal mortality due to early stopping of the largest included trial for safety reasons after the advice of the Data and Safety Monitoring Board. Furthermore, only two RCTs were eligible for the IPD-MA; thus, the possibility to assess severe adverse neonatal outcomes with few events was limited.ConclusionsIn this study, we found that, overall, IOL at 41 weeks improved perinatal outcome compared with expectant management until 42 weeks without increasing the cesarean delivery rate. This benefit is shown only in nulliparous women, whereas for multiparous women, the incidence of mortality and morbidity was too low to demonstrate any effect. The magnitude of risk reduction of perinatal mortality remains uncertain. Women with pregnancies approaching 41 weeks should be informed on the risk differences according to parity so that they are able to make an informed choice for IOL at 41 weeks or expectant management until 42 weeks.Study Registration: PROSPERO CRD42020163174Mårten Alkmark and co-workers report on a meta-analysis of randomized trials of labour induction at 41 weeks'' gestation as compared with expectant management until 42 weeks. 相似文献
978.
979.
980.